2214 results
Article
We respond to NICE provisional decision to not recommend elacestrant in England
Claire Rowney, chief executive at Breast Cancer Now, said:
Clinical trial for secondary ER-positive, HER2-negative breast cancer
Take part in a clinical trial exploring whether adding a drug called ipatasertib to standard treatment can improve people’s response to breast cancer treatment. The study's title is 'FAIM – Phase II study'.
Article
Breast Cancer Now response to the death of Linda Nolan
Claire Rowney, CEO, Breast Cancer Now says:
Event
Quiz nights
Personal Story
Reuben's story
After his breast cancer diagnosis, Reuben wants to do everything he can to raise awareness of male breast cancer.
Article
Understanding the risks of late side effects to the heart after radiotherapy
How Breast Cancer Now Voices helped researchers understand people’s perceptions and understanding of late side effects to the heart.
Personal Story
Amy talks body confidence and trying for a baby after breast cancer
At 25, with no family history of breast cancer, Amy’s diagnosis came as a massive shock. Now, 4 years on, she’s feeling stronger than ever.
Personal Story
Hoping to click: dating and breast cancer
Seven women share their stories of dating after a breast cancer diagnosis.
Article
We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
Article
An update on our work in Northern Ireland
Since we updated you in summer, we’ve continued to work towards our goal that by 2050, everyone diagnosed with breast cancer lives and is supported to live well in Northern Ireland.
Article
Fiona - on inspiring change in the face of adversity
In this episode, Laura talks to Fiona a Breast Cancer Voice and active campaigner for disability issues about challenges she faced during breast cancer treatment and inspiring change in the face of adversity.
Healthcare Information
Family history: Assessing your breast cancer risk
Find out more about a family history risk assessment, including whether you may need one and what happens after the assessment.